URL: http://antibodyregistry.org/AB_2722017
Proper Citation: DSHB Cat# CPTC-AKT2-3, RRID:AB_2722017
Target Antigen: V-Akt Murine Thymoma Viral Oncogene Homolog 2 Peptide 4
Host Organism: mouse
Clonality: monoclonal
Comments: Application(s): Date Deposited: 05/10/2017
Expand AllWe found {{ ctrl2.mentions.all_count }} mentions in open access literature.
We have not found any literature mentions for this resource.
We are searching literature mentions for this resource.
Most recent articles:
{{ mention._source.dc.creators[0].familyName }} {{ mention._source.dc.creators[0].initials }}, et al. ({{ mention._source.dc.publicationYear }}) {{ mention._source.dc.title }} {{ mention._source.dc.publishers[0].name }}, {{ mention._source.dc.publishers[0].volume }}({{ mention._source.dc.publishers[0].issue }}), {{ mention._source.dc.publishers[0].pagination }}. (PMID:{{ mention._id.replace('PMID:', '') }})
Check
for all resource mentions.
A list of researchers who have used the resource and an author search tool
Find mentions based on location
{{ ctrl2.mentions.errors.location }}
A list of researchers who have used the resource and an author search tool. This is available for resources that have literature mentions.
No rating or validation information has been found for V-Akt Murine Thymoma Viral Oncogene Homolog 2 Peptide 4 antibody - Clinical Proteomics Technologies for Cancer; National Cancer Institute.
No alerts have been found for V-Akt Murine Thymoma Viral Oncogene Homolog 2 Peptide 4 antibody - Clinical Proteomics Technologies for Cancer; National Cancer Institute.
Source: Antibody Registry
